Aerwave Medical
About:
Aerwave Medical develops an alternative to traditional medications used to treat COPD and asthma.
Website: https://aerwavemed.com
Description:
Aerwave Medical develops an alternative to traditional medications used to treat COPD and asthma. Its interventional approach provides improvement for patients who are refractory to drug therapy, enabling healthcare institutions to address a significant unmet medical need. The company was founded in 2020 and is based in New York, New York.
Total Funding Amount:
$7.97M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
New York, New York, United States
Founded Date:
2020-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2022-07-15
IPO Status:
Private
Industries:
© 2025 bioDAO.ai